| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/05/2023 | STRATA Skin Sciences, Inc. | SSKN | Grant | | 36.4k | $1.03 | $37.5k | | 07/05/2023 |
| 06/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 4.5k | $0.00 | $0 | | 06/01/2023 |
| 06/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Grant | Stock Option (Right to Buy) | 15.8k | $8.70 | $137k | | 06/01/2023 |
| 06/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted Stock Units | 4.7k | $0.00 | $0 | | 06/01/2023 |
| 05/19/2023 | PhaseBio Pharmaceuticals Inc | PHAS | Exercise | Restricted Stock Units | 2.5k | $0.00 | $0 | | 05/19/2023 |
| 06/22/2022 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 30k | $1.62 | $48.6k | | 06/22/2022 |
| 06/03/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 3.4k | $0.00 | $0 | | 06/02/2022 |
| 06/02/2022 | Aclaris Therapeutics, Inc. | ACRS | Grant | Stock Option (Right to Buy) | 15.8k | $14.48 | $228.1k | | 06/02/2022 |
| 06/02/2022 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted Stock Units | 4.5k | $0.00 | $0 | | 06/02/2022 |
| 05/19/2022 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 17.5k | $0.84 | $14.7k | | 05/19/2022 |
| 05/19/2022 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Restricted Stock Units | 3.8k | $0.00 | $0 | | 05/19/2022 |
| 05/19/2022 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 11.8k | $0.84 | $10k | | 05/19/2022 |
| 05/19/2022 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Restricted Stock Units | 2.5k | $0.00 | $0 | | 05/19/2022 |
| 03/25/2022 | STRATA Skin Sciences, Inc. | SSKN | Purchase | SSKN Common Stock | 17k | $1.73 | $29.4k | | 03/25/2022 |
| 03/24/2022 | STRATA Skin Sciences, Inc. | SSKN | Purchase | SSKN Common Stock | 14.8k | $1.58 | $23.4k | | 03/24/2022 |
| 01/10/2022 | Clearside Biomedical, Inc. | CLSD | Exercise | Stock Option (right to buy) | 22.7k | $0.15 | $3.4k | | 01/10/2022 |
| 09/14/2021 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 28k | $2.80 | $78.4k | | 09/14/2021 |
| 08/20/2021 | STRATA Skin Sciences, Inc. | SSKN | Grant | Non-Qualified Stock Option Agreement for SSKN Common Stock | 411.1k | $1.42 | $583.8k | | 08/20/2021 |
| 07/20/2021 | STRATA Skin Sciences, Inc. | SSKN | Grant | | 20k | $0.00 | $0 | | 07/20/2021 |
| 07/20/2021 | STRATA Skin Sciences, Inc. | SSKN | Grant | | 21.6k | $0.00 | $0 | | 07/20/2021 |
| 06/10/2021 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 25k | $3.11 | $77.8k | | 06/10/2021 |
| 06/03/2021 | Aclaris Therapeutics, Inc. | ACRS | Grant | Stock Option (Right to Buy) | 12.2k | $21.90 | $268.3k | | 06/03/2021 |
| 06/03/2021 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted Stock Units | 3.4k | $0.00 | $0 | | 06/03/2021 |
| 12/04/2020 | Bausch Health Companies Inc. | BHC | Sale | Common Shares, No Par Value | 114.1k | $19.87 | $2.3M | | 12/04/2020 |
| 12/04/2020 | Bausch Health Companies Inc. | BHC | Exercise | Non-qualified Stock Options (right To Purchase) | 114.1k | $14.38 | $1.6M | | 12/04/2020 |
| 11/27/2020 | Bausch Health Companies Inc. | BHC | Sale | Common Shares, No Par Value | 13.7k | $19.63 | $268.2k | | 11/23/2020 |
| 11/27/2020 | Bausch Health Companies Inc. | BHC | Exercise | Non-qualified Stock Options (right To Purchase) | 13.7k | $14.38 | $196.5k | | 11/23/2020 |
| 11/24/2020 | Bausch Health Companies Inc. | BHC | Sale | Common Shares, No Par Value | 21.7k | $19.63 | $425.2k | | 11/23/2020 |
| 11/24/2020 | Bausch Health Companies Inc. | BHC | Exercise | Non-qualified Stock Options (right To Purchase) | 21.7k | $14.38 | $311.4k | | 11/23/2020 |
| 11/23/2020 | Bausch Health Companies Inc. | BHC | Exercise | Non-qualified Stock Options (right To Purchase) | 1.5k | $14.38 | $21.3k | | 11/23/2020 |
| 11/23/2020 | Bausch Health Companies Inc. | BHC | Sale | Common Shares, No Par Value | 1.5k | $19.63 | $29.1k | | 11/23/2020 |
| 09/08/2020 | Bausch Health Companies Inc. | BHC | Sale | Common Shares, No Par Value | 5.7k | $16.17 | $91.6k | | 09/08/2020 |
| 08/18/2020 | Clearside Biomedical, Inc. | CLSD | Purchase | Common Stock | 5.6k | $1.78 | $9.9k | | 08/18/2020 |
| 08/17/2020 | Bausch Health Companies Inc. | BHC | Payment of Exercise | Common Shares, No Par Value | 4.6k | $17.48 | $79.8k | | 08/17/2020 |
| 06/18/2020 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 25k | $2.00 | $50k | | 06/18/2020 |
|